Bmab1700
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bmab1700, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma [Phase 1]